chr12-121934277-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_144668.6(CFAP251):c.919G>A(p.Val307Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0459 in 1,612,296 control chromosomes in the GnomAD database, including 2,057 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_144668.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP251 | NM_144668.6 | c.919G>A | p.Val307Ile | missense_variant | 5/22 | ENST00000288912.9 | NP_653269.3 | |
CFAP251 | NM_001178003.2 | c.919G>A | p.Val307Ile | missense_variant | 5/18 | NP_001171474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP251 | ENST00000288912.9 | c.919G>A | p.Val307Ile | missense_variant | 5/22 | 1 | NM_144668.6 | ENSP00000288912 | ||
CFAP251 | ENST00000397454.2 | c.919G>A | p.Val307Ile | missense_variant | 5/18 | 1 | ENSP00000380595 | P1 | ||
CFAP251 | ENST00000546044.1 | n.28G>A | non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0363 AC: 5521AN: 152146Hom.: 132 Cov.: 32
GnomAD3 exomes AF: 0.0419 AC: 10450AN: 249180Hom.: 270 AF XY: 0.0436 AC XY: 5895AN XY: 135168
GnomAD4 exome AF: 0.0469 AC: 68464AN: 1460032Hom.: 1923 Cov.: 30 AF XY: 0.0472 AC XY: 34280AN XY: 726384
GnomAD4 genome AF: 0.0363 AC: 5532AN: 152264Hom.: 134 Cov.: 32 AF XY: 0.0355 AC XY: 2645AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at